A synthetic peptide for use as a blocking control in assays to test for specificity of BBS2 antibody, Alternative Names: BBS2 control peptide, BBS2 antibody Blocking Peptide, Anti-BBS2 Blocking Peptide, Bardet-Biedl syndrome 2 Blocking Peptide, BBS Blocking Peptide, MGC20703 Blocking Peptide, BBS2, BBS-2, BBS 2, BBS-2 Blocking Peptide, BBS 2 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
BBS2
(Bardet-Biedl Syndrome 2 (BBS2))
Hintergrund
This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and mental retardation. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with six other BBS proteins.